Adapting the Sensory Environment to Reduce Stress in Children With Autism During Dental Visits
SMILED
Assessment of Dental-related Physiological Stress and Sensory Profiles in Children With Autism Spectrum Disorder Undergoing Routine Dental Care in Regular and Sensory-adapted Environments, and Associated Parental Stress: a Prospective Single-arm Interventional Study
2 other identifiers
interventional
40
1 country
1
Brief Summary
This study aims to evaluate the impact of a sensory-adapted dental environment (SADE) on the stress levels and behavioral responses of children with autism spectrum disorder (ASD) during dental visits. Children with ASD often experience sensory sensitivities, making traditional dental care challenging and stressful. In this study, 40 children aged 8 to 12 diagnosed with ASD, along with their parents or legal guardians, will participate in two standard dental visits spaced 30 days apart. The first visit will take place under standard clinical conditions, while the second visit will utilize a sensory-adapted dental environment featuring modified visual elements (such as dark protective glasses), auditory (noise-canceling headphones or relaxing music), taste (unflavored toothpaste), smell (sweet orange essential oil) and tactile adjustments (a weighted blanket). The study will measure stress using objective tools, including continuous digital biomarkers of stress recorded via wristbands (such as heart rate, electrodermal activity, accelerometer data, actigraphy, movement intensity, step count, metabolic equivalent of task, skin temperature, and peripheral body orientation) and the analysis of salivary lysozyme and cortisol levels in both children and parents. Additionally, standardized psychological questionnaires will be used to assess the child's sensory profile, as well as parental stress and coping strategies. The findings will help determine whether modifying the sensory environment can effectively reduce anxiety and improve the dental care experience for children with autism.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2026
CompletedFirst Submitted
Initial submission to the registry
October 7, 2026
CompletedFirst Posted
Study publicly available on registry
October 21, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 13, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 13, 2026
October 21, 2026
October 1, 2026
1 month
October 7, 2026
October 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Change in Child Electrodermal Activity (EDA) via Wearable Device (Empatica EmbracePlus)
Continuous recording of skin conductance (in microSiemens, μS) via Empatica EmbracePlus to to measure child physiological stress during dental visits in RDE versus SADE conditions.
Measured continuously in real-time during both dental visits (Visit 1 and Visit 2), approx. 30-90 minutes per visit.
Change in Child Heart Rate (HR) via Wearable Device (Empatica EmbracePlus)
Continuous recording of heart rate (in beats per minute, bpm) via Empatica EmbracePlus to measure child physiological stress during dental visits in RDE versus SADE conditions.
Measured continuously in real-time during both dental visits (Visit 1 and Visit 2), approx. 30-90 minutes per visit.
Change in Child Respiration Rate (RR) via Wearable Device (Empatica EmbracePlus)
Continuous recording of respiratory rate (in breaths per minute, rpm) via Empatica EmbracePlus to assess child physiological stress during dental visits in RDE versus SADE conditions.
Measured continuously in real-time during both dental visits (Visit 1 and Visit 2), approx. 30-90 minutes per visit.
Change in Child Skin Temperature (ST) via Wearable Device (Empatica EmbracePlus)
Continuous recording of skin temperature (in degrees Celsius, °C) via Empatica EmbracePlus to measure child physiological stress during dental visits in RDE versus SADE conditions.
Measured continuously in real-time during both dental visits (Visit 1 and Visit 2), approx. 30-90 minutes per visit.
Change in Child Actigraphy-Derived Physical Activity Metrics via Wearable Device (Empatica EmbracePlus)
Continuous recording of actigraphy data derived from the tri-axial accelerometer (in gravitational force units, g) to assess child physical restlessness during dental visits in RDE versus SADE conditions.
Measured continuously in real-time during both dental visits (Visit 1 and Visit 2), approx. 30-90 minutes per visit.
Change in Child Metabolic Equivalent of Task (MET) via Wearable Device (Empatica EmbracePlus)
Estimation of child energy expenditure measured in MET values via Empatica EmbracePlus during dental visits in RDE versus SADE conditions.
Measured continuously in real-time during both dental visits (Visit 1 and Visit 2), approx. 30-90 minutes per visit.
Change in Child Salivary Lysozyme Levels
Quantification of salivary lysozyme concentration (in µg/mL) assessed via ELISA from saliva samples collected using the spit method immediately post-visit to measure child stress changes between RDE and SADE visits.
Saliva samples collected immediately post-visit at Visit 1 (Day 1) and Visit 2 (approx. Day 30), covering a total study period of approx. 30 days; samples subsequently analyzed in the laboratory.
Change in Child Salivary Cortisol Levels
Quantification of salivary cortisol concentration (in nmol/L) assessed via ELISA from saliva samples collected using the spit method immediately post-visit to measure child stress changes between RDE and SADE visits.
Saliva samples collected immediately post-visit at Visit 1 (Day 1) and Visit 2 (approx. Day 30), covering a total study period of approx. 30 days; samples subsequently analyzed in the laboratory.
Secondary Outcomes (14)
Sensory Monitoring of Individual Level Experiences in Dentistry (SMILED Scale)
Assessed at Visit 1 (Day 1) and Visit 2 (approx. Day 30), covering a total study duration of approximately 30 days.
Child Sensory Profile (SSP-2)
Assessed at baseline during Visit 1 (Day 1).
Child Emotional State
Assessed immediately before and immediately after each dental visit at Visit 1 (Day 1) and Visit 2 (approx. Day 30), covering a total study period of approximately 30 days.
Change in Parental Electrodermal Activity (EDA) via Wearable Device (Empatica EmbracePlus)
Measured continuously in real-time during both dental visits (Visit 1 and Visit 2), approx. 30-90 minutes per visit.
Change in Paretal Heart Rate (HR) via Wearable Device (Empatica EmbracePlus)
Measured continuously in real-time during both dental visits (Visit 1 and Visit 2), approx. 30-90 minutes per visit.
- +9 more secondary outcomes
Study Arms (1)
SADE Intervention Group
EXPERIMENTALA prospective, single-arm, non-randomized interventional study where all participating complete two sequential, standardized afternoon dental visits spaced 30 days apart. Visit 1 is conducted under standard clinical conditions (Regular Dental Environment - RDE) on a clinical chair without modifications, serving as the baseline reference. Visit 2 is conducted in a single-chair operatory utilizing a Sensory-Adapted Dental Environment (SADE) featuring multi-sensory adjustments. Both visits involve dental procedures performed by the same pediatric dentist, alongside real-time physiologic stress monitoring (via Empatica EmbracePlus wristbands), salivary sample collection (lysozyme and cortisol assays), pictorial self-report mood assessments, and psychological questionnaires (custom SMILED Scale, SSP-2, PSI-IV, CISS, STAI).
Interventions
A multi-sensory adaptation of the dental operatory applied during the second study visit (Visit 2). The modification includes five components: visual (yellow-filtered operating lamp and dark protective glasses), auditory (noise-canceling headphones or relaxing music), tactile (a weighted blanket), olfactory (sweet orange essential oil diffusion), and gustatory (unflavored prophylaxis toothpaste). The first visit serves as the control condition using a Regular Dental Environment (RDE) without these modifications.
Eligibility Criteria
You may qualify if:
- Age: 8-12 years.
- Diagnosis of Autism Spectrum Disorder (ASD): Official ASD diagnosis according to ICD-10, ICD-11, or DSM-5 criteria, confirmed by medical documentation from a psychiatrist/pediatric psychiatrist, a psychologist's opinion, or a diagnostic team.
- No Prior Contact: No prior contact with the proposed intervention (e.g., the specific calming techniques used in the study).
- Absence of Profound Cognitive Deficits: Required level of intellectual functioning: IQ \> 70.
- Stable Mental and Somatic Health Status: Over the last 30 days, with no sudden health exacerbations (e.g., psychiatric episodes, hospitalizations).
- Consent to Participate: Written informed consent obtained from the parent/legal guardian, along with the child's assent appropriate to their developmental level.
- Role and Age: Parent or legal guardian of the minor participant diagnosed with ASD, aged over 18 years.
- Consent to Participate: Written informed consent obtained from the parent/legal guardian as a study participant.
- Health Status: Stable mental and somatic health status over the last 30 days.
You may not qualify if:
- Current Anxiety Treatment: Child undergoing psychological or pharmacological therapy directly aimed at treating anxiety (e.g., CBT, anti-anxiety medications).
- Changes in Psychotropic Medication: Initiation of a new psychotropic drug or dosage change within the 4 weeks prior to the study.
- Diagnosis of Other Mental Disorders: Schizophrenia, schizoaffective disorders, or bipolar affective disorders that could interfere with the study.
- Clinically Significant Suicidal Ideation: Present currently or in the recent history.
- Persistent Aggression or Self-Aggression: Behaviors that may prevent the safe execution of the dental procedure.
- Somatic Comorbidities Co-occurring with ASD: Conditions that may increase stress-related risks, such as pharmacologically uncontrolled epilepsy, heart failure, unstable type 1 diabetes, or central nervous system disorders.
- Significant Family Life Instability: Within the last 4 weeks (e.g., relocation, divorce, crisis interventions).
- Oral Pain or Salivary Disorders: Dental pain originating from the oral cavity or salivary gland secretion disorders in the child.
- Lack of Consent: Absence of written consent from the parent/legal guardian or lack of the child's assent to participate.
- Upper Respiratory Tract Infection: Occurring within the last 7 days.
- Lack of Consent: Absence of written consent from the parent/legal guardian to participate as a study subject.
- Oral Pain or Salivary Disorders: Dental pain originating from the oral cavity or salivary gland secretion disorders in the parent/legal guardian.
- Severe Mental Function Disorders: Diagnosed severe mental impairment requiring therapy with high doses of neurotropic drugs.
- Significant Family Life Instability: Within the last 4 weeks (e.g., relocation, divorce, crisis interventions).
- Upper Respiratory Tract Infection: Occurring within the last 7 days. Because the study is conducted in parent-child dyads, the refusal or withdrawal of consent by one participant automatically excludes the other from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Developmental Age Dentistry, Institute of Dentistry, Jagiellonian University Medical College
Krakow, Lesser Poland Voivodeship, 31-155, Poland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Iwona Gregorczyk-Maga, Professor
Department of Developmental Age Dentistry, Institute of Dentistry, Jagiellonian University Medical College
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lekarz dentysta
Study Record Dates
First Submitted
October 7, 2026
First Posted
October 21, 2026
Study Start
October 1, 2026
Primary Completion (Estimated)
November 13, 2026
Study Completion (Estimated)
November 13, 2026
Last Updated
October 21, 2026
Record last verified: 2026-10